Tyrosine and phenylalanine restriction induces G0/G1 cell cycle arrest in murine melanoma in vitro and in vivo.

Tyr-Phe and Met limitation in vitro inhibited cell proliferation and proliferating cell nuclear antigen (PCNA) expression to a greater extent than serum limitation. Tyr-Phe and serum limitation arrested cells in the G0/G1 phase; Met limitation blocked cells in the G0/G1 and S phases. Tyr-Phe limitation progressively decreased cyclin D1 expression to 30% of control within four days and did not affect expression of cyclin D3 or cyclin-dependent kinase (CDK2, CDK4, and CDK5) expression, Met limitation decreased cyclin D3 expression to 25% of control and CDK2 expression to 32% of control by Day 4 and did not affect expression of cyclin D1, CDK4, and CDK5. Serum limitation inhibited cyclin D1 and cyclin D3 expression to 24% of control after four days and did not effect CDK expression. Expression of two CDK inhibitors, p21WAF1/Cip1 and p27Kip1, was not changed by amino acid or serum limitation. Dietary restriction of Tyr-Phe in mice bearing subcutaneous B16BL6 melanoma tumors decreased tumor growth rate compared with mice fed a normal diet. Tumors from Tyr-Phe-restricted mice exhibited decreased PCNA expression, G0/G1 phase cell cycle arrest, and reduced cyclin D1 expression. These data indicate that decreased tumor growth in vivo associated with dietary restriction of Tyr and Phe is cell cycle specific.

[1]  M. Merino,et al.  Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions , 1995, Nature Medicine.

[2]  H. Matsuda,et al.  Cell‐cycle‐dependent invasion in vitro by rat ascites hepatoma cells , 1995, International journal of cancer.

[3]  H. Koeffler,et al.  Role of the cyclin-dependent kinase inhibitors in the development of cancer. , 1995, Blood.

[4]  K. Hirose,et al.  Relationships among the expression of epidermal growth factor receptor, proliferating cell nuclear antigen labeling index, and lymph node metastasis in gastric cancer. , 1995, Oncology.

[5]  J. Massagué,et al.  p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. , 1995, Cancer research.

[6]  G. Siegal,et al.  Amino acid transport systems modulate human tumor cell growth and invasion: a working hypothesis. , 1995, Medical hypotheses.

[7]  C. R. Teixeira,et al.  Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma. , 1995, Oncology.

[8]  W. Mercer,et al.  p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. , 1995, Cancer research.

[9]  C. Sherr G1 phase progression: Cycling on cue , 1994, Cell.

[10]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[11]  I. Herskowitz,et al.  Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle , 1994, Cell.

[12]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[13]  L. Bonetta,et al.  CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. , 1994, Oncogene.

[14]  M. Ewen,et al.  TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest , 1993, Cell.

[15]  Elstad Ca,et al.  Modulation of B16-BL6 murine melanoma metastatic phenotype by tyrosine and phenylalanine restriction in the absence of host selection pressures. , 1993 .

[16]  V. Ferrans,et al.  Localization of basic fibroblast growth factor in bovine endothelial cells: immunohistochemical and biochemical studies. , 1993, Experimental cell research.

[17]  S. Epstein,et al.  Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Epstein,et al.  Inhibition of Smooth Muscle Cell Proliferation by an Antisense Oligodeoxynucleotide Targeting the Messenger RNA Encoding Proliferating Cell Nuclear Antigen , 1992, Circulation.

[19]  Elstad Ca,et al.  Phenotypic stability of B16-BL6 melanoma exposed to low levels of tyrosine and phenylalanine. , 1990 .

[20]  D. Lane,et al.  Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. , 1990, Journal of cell science.

[21]  R. Bravo,et al.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ , 1987, Nature.

[22]  J. Starkey,et al.  Dietary restriction of tyrosine and phenylalanine: inhibition of metastasis of three rodent tumors. , 1987, Journal of the National Cancer Institute.

[23]  T. McMillan,et al.  Enhancement of experimental metastasis by pretreatment of tumour cells with hydroxyurea , 1986, International journal of cancer.

[24]  J. V. Von Roenn,et al.  Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study. , 1986, Cancer research.

[25]  W. Ershler,et al.  Slower B16 melanoma growth but greater pulmonary colonization in calorie-restricted mice. , 1986, Journal of the National Cancer Institute.

[26]  V. Siskind,et al.  Risk factors for cutaneous melanoma in Queensland. , 1986, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[27]  F. Bosman,et al.  Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. , 1985, Cytometry.

[28]  G. Meadows,et al.  Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma. , 1983, Cancer research.

[29]  G. Meadows,et al.  Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy. , 1982, Cancer research.

[30]  I. Fidler,et al.  In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. , 1980, Cancer research.

[31]  I. Hart The selection and characterization of an invasive variant of the B16 melanoma. , 1979, The American journal of pathology.